StocksTelegraph
S&P 500NASDAQDOWRUSSELL
← All articles

Investing

Carter Bankshares, Inc. (CARE) Receives Hold Rating; Limited Upside Potential

Hasnain Khan
Carter Bankshares, Inc. (CARE) Receives Hold Rating; Limited Upside Potential

Carter Bankshares, Inc. (ticker: CARE) recently received a ‘Hold’ rating from Mikhail Paramonov of Freedom Broker, citing a price target that aligns closely with the current trading price. As of now, CARE shares sit at $26.21, with a target of $27, indicating limited upside potential in the near term for investors considering a stake in the bank.

Recent Price Action

The stock of Carter Bankshares has exhibited notable volatility in recent sessions, reflecting a broader market sentiment that may indicate caution among investors. Currently trading at $26.21, CARE’s price has seen a decrease of $0.86, or 3.18%, from the previous day’s close. Over the past week, the stock has hovered significantly below its 52-week high of $58.25, showing a stark contrast compared to its yearly low, which is still comparatively high at $4.35. With a market capitalization of approximately $582 million and a beta of 0.513, defined market reactions to this stock remain relatively stable, suggesting a defensive stance among long-term investors. The trading volume of 302,506 shares exceeded the recent average volume of 281,369, indicating increased interest which may signal shifts in investor outlook.

Historical Performance

A deeper dive into Carter Bankshares’ historical performance reveals a mixed bag. The stock has faced a subdued monthly performance of -0.2%, reflecting slight strain in the recent trading landscape. Over the past three months, however, CARE has rebounded with a compelling quarterly performance of 9.55%. Year-over-year, the stock has displayed modest resilience, achieving a gain of 15.67%. The volatility metrics also substantiate this mixed signal, with a weekly volatility of 2.75% juxtaposed against a lower monthly volatility of 2.19%, indicating stability in certain time frames while experiencing fluctuations in others. Notably, the 10-day average volume at 318,523 reflects an uptick in trading activity, suggesting varying investor perspectives on the stock’s future direction.

Earnings Analysis

Carter Bankshares’ earnings report from April 23, 2026, presented a clear challenge, with actual earnings per share (EPS) of $0.40 falling significantly short of the estimated $3.91. This surprising figure, leading to a notable surprise factor of -89.77%, raises concerns regarding the bank’s operational efficiency and earnings predictability. In contrast, the previous earnings report showcased a more favorable outcome where the bank reported an EPS of $0.41 against a lower estimate of $0.33, reflecting a positive surprise of 24.24%. This inconsistent earnings profile poses potential risks for investors seeking reliable performance indicators.

Analyst / Consensus View

Currently, the consensus among analysts is notably tepid. Analyst Mikhail Paramonov has assigned a ‘Hold’ rating with a price target set at $27, which coincides precisely with the average, high, and low predictions, indicating a consensus view that anticipates little immediate change. Out of one total rating assessed, there are no ‘Buy’ recommendations, one ‘Hold’, and zero ‘Sell’ ratings. Such a singular stance casts a shadow over investor enthusiasm and suggests a wait-and-see approach amidst unclear prospects.

Stock Grading or Fundamental View

Carter Bankshares carries a Stocks Telegraph grading score of 59, suggesting that while the company has some resilient qualities, there are underlying risks that could influence its growth trajectory. This score places CARE in a more cautious investment category, indicating the necessity for further developments in business strategy or market conditions to elevate confidence in future performance.

Conclusion

In summary, Carter Bankshares appears more suited for conservative investors inclined towards dividends and defensive stocks than those seeking aggressive growth opportunities. While the recent ‘Hold’ rating underscores the potential for stability, the stark earnings disparity and limited upside potential caution against an impulsive buy. Investors should closely monitor upcoming earnings reports and broader market indicators that could provide a clearer understanding of CARE’s recovery path. The company remains an interesting watch for those who appreciate a blend of risk and stability in the financial sector, but caution is advised as the bank navigates its next steps.